Legal & General Group PLC Cytokinetics Inc Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Legal & General Group PLC holds 168,900 shares of CYTK stock, worth $8.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

168,900

Previous 143,126 18.01%

Holding current value

$8.84 Million

Previous $10 Million 8.8%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $1.23 Million - $1.93 Million	25,774 Added 18.01%	168,900 $9.15 Million
Q1 2024 May 14, 2024	SELL	$63.75 - $108.06 $7.86 Million - $13.3 Million	-123,361 Reduced 46.29%	143,126 $10 Million
Q4 2023 Feb 15, 2024	SELL	$26.88 - $83.49 $18,520 - $57,524	-689 Reduced 0.26%	266,487 $22.2 Million
Q3 2023 Nov 14, 2023	SELL	$29.46 - $36.61 $40,065 - $49,789	-1,360 Reduced 0.51%	267,176 $7.87 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $978 - $1,222	30 Added 0.01%	268,536 $8.76 Million
Q1 2023 May 15, 2023	BUY	$33.36 - $45.71 $63,617 - $87,168	1,907 Added 0.72%	268,506 $9.45 Million
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $253,573 - $362,318	7,089 Added 2.73%	266,599 $12.2 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $624,733 - $883,769	16,210 Added 6.66%	259,510 $12.6 Million
Q2 2022 Aug 22, 2022	BUY	$33.93 - $48.92 $133,853 - $192,989	3,945 Added 1.65%	243,300 $9.56 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $1.06 Million - $1.65 Million	35,768 Added 17.57%	239,355 $8.81 Million
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $313,890 - $423,820	9,138 Added 4.7%	203,587 $9.28 Million
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $715,440 - $1.38 Million	38,589 Added 24.76%	194,449 $6.95 Million
Q2 2021 Aug 12, 2021	SELL	$19.79 - $26.99 $911,646 - $1.24 Million	-46,066 Reduced 22.81%	155,860 $3.08 Million
Q1 2021 May 17, 2021	BUY	$18.57 - $25.68 $26,517 - $36,671	1,428 Added 0.71%	201,926 $4.7 Million
Q4 2020 Feb 12, 2021	BUY	$15.26 - $28.61 $11,506 - $21,571	754 Added 0.38%	200,498 $4.17 Million
Q3 2020 Nov 13, 2020	BUY	$20.58 - $28.96 $648,043 - $911,921	31,489 Added 18.72%	199,744 $4.32 Million
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $210,701 - $465,622	18,897 Added 12.65%	168,255 $3.97 Million
Q1 2020 May 14, 2020	BUY	$8.75 - $16.3 $7,708 - $14,360	881 Added 0.59%	149,358 $1.76 Million
Q4 2019 Feb 13, 2020	BUY	$7.95 - $11.84 $92,196 - $137,308	11,597 Added 8.47%	148,477 $1.58 Million
Q3 2019 Nov 13, 2019	BUY	$10.82 - $14.25 $18,274 - $24,068	1,689 Added 1.25%	136,880 $1.56 Million
Q2 2019 Aug 14, 2019	BUY	$7.95 - $11.25 $62,948 - $89,077	7,918 Added 6.22%	135,191 $1.52 Million
Q1 2019 May 15, 2019	BUY	$5.95 - $10.19 $75,142 - $128,689	12,629 Added 11.02%	127,273 $1.03 Million
Q4 2018 Feb 15, 2019	SELL	$5.91 - $9.29 $2,003 - $3,149	-339 Reduced 0.29%	114,644 $716,000
Q3 2018 Nov 20, 2018	BUY	$6.4 - $9.85 $102,739 - $158,122	16,053 Added 16.23%	114,983 $1.13 Million
Q2 2018 Aug 10, 2018	BUY	$6.9 - $9.9 $38,812 - $55,687	5,625 Added 6.03%	98,930 $818,000
Q1 2018 May 17, 2018	BUY	$7.2 - $10.05 $24,069 - $33,597	3,343 Added 3.72%	93,305 $674,000
Q4 2017 Feb 13, 2018	BUY	$7.25 - $15.65 $652,224 - $1.41 Million	89,962	89,962 $734,000

Others Institutions Holding CYTK

# of Institutions

406

Shares Held

126M

Call Options Held

3.29M

Put Options Held

2.01M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.93B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Cytokinetics Inc Transaction History